O D negative red cell toolkit
Information to help clinical and laboratory staff prevent wastage, and promote the safe and appropriate use, of O D negative red cells
Demand in 2022
Total red cell usage is falling due to improved surgical techniques and the implementation of Patient Blood Management (PBM) initiatives including the use of alternatives. However, demand for O D negative is increasing. Stability of the supply chain for universal components such as O D negative red cells remains a challenge for most blood services around the world and we're working hard to ensure adequate supplies are available when required.
Efforts are primarily focused on improvement of donor marketing to achieve a blood group mix appropriate to clinical demands. Approximately 7% of the UK population is O D negative, but average demand is greater than 13% and rising (this figure includes the impact of COVID).
We encourage you to make a difference and consider a range of initiatives to help conserve this precious resource.
NBTC appropriate specification for emergency red cells (JPAC website)
Top tips to reduce the usage and wastage of O D Negative red cells from the East of England regional transfusion committee
Good practice from Trusts
Experiences and initiatives on successfully managing stocks, wastage and appropriate use, for more information please contact the Trust.
If you would like to share your Trust's good practice please contact your Patient Blood Management Practitioner or Customer Service Manager.
Designed for you to use alongside appropriate text in presentations and educational resources. Please acknowledge NHSBT as the author and please email our customer service team to let us know you've used them.
Stock sharing (PPT)
Blood Stocks Management Scheme
See the further resources section on the Publications page, for using the issuable stock index (ISI), and learning points on O D negative.